Related Experiment Video
Updated: Jul 5, 2026
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
What is new in the 2006 ACC/AHA guidelines on valvular heart disease?
1Veterans Affairs Medical Center, Medical Service (111), 2002 Holcombe Boulevard, Houston, TX 77030, USA. blaseanthony.carabello@med.va.gov
Insights
The 2006 American College of Cardiology/American Heart Association guidelines for valvular heart disease recommend a more aggressive treatment strategy. Key updates include risk stratification for aortic stenosis and earlier intervention for mitral regurgitation.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Practice Guidelines
Background:
- The American College of Cardiology/American Heart Association published updated guidelines for valvular heart disease management in June 2006.
- These guidelines supersede the 1998 recommendations, incorporating new data and evolving clinical practices.
Purpose of the Study:
- To summarize salient changes in the 2006 valvular heart disease guidelines compared to the 1998 version.
- To highlight key shifts in management strategies for various valvular heart conditions.
Main Methods:
- Review and analysis of the 2006 American College of Cardiology/American Heart Association Guidelines for the Management of Patients with Valvular Heart disease.
- Comparison of recommendations between the 2006 and 1998 guideline documents.
Main Results:
- The 2006 guidelines advocate a more aggressive approach to managing most valve lesions.
- Specific changes include recommended inotropic reserve detection for low-gradient, low ejection fraction aortic stenosis and softened recommendations for vasodilator use in aortic regurgitation.
- Earlier surgical intervention and mitral repair are emphasized for mitral regurgitation, with a trend towards biological valves over mechanical prostheses.
Conclusions:
- The updated guidelines offer a more aggressive management strategy for valvular heart disease.
- These comprehensive guidelines provide essential direction for complex patient care.
- Key updates reflect advancements in risk stratification and treatment modalities for valvular heart conditions.
Abstract:
In June 2006, the American College of Cardiology/American Heart Association Guidelines for the Management of Patients with Valvular Heart disease were published. Although many recommendations were unchanged from the 1998 guidelines, several new suggestions bear comment. The new guidelines favor a more aggressive approach to most valve lesions. For patients with low-gradient, low ejection fraction aortic stenosis, detecting inotropic reserve to help risk stratify such patients is now recommended. In the field of aortic regurgitation, the use of vasodilators to forestall surgery has been called into doubt by newer data; thus, recommendations for vasodilator use have been softened. For patients with mitral regurgitation, earlier surgery and mitral repair are highlighted. The new guidelines also reflect a growing trend toward the use of biological valves instead of mechanical prostheses. This 150-page document with more than 1000 references should be useful in guiding practice for these often complex patients. This article summarizes some of the more salient changes in 2006 compared with those of 1998.
More Related Videos
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
01:25Aortic Regurgitation III: Medical Management
01:16Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
01:27Mitral Stenosis IV: Nursing Management
01:21Rheumatic Heart Disease III: Medical Management
01:25Mitral Regurgitation III: Medical Management